Product Overview

Desolivo Nasal Spray is a pharmaceutical nasal spray containing Desmopressin at a strength of 0.1 mg/mL. The product is presented in a 50-metered-dose nasal spray format and belongs to the antidiuretic therapy segment.

Desmopressin is a synthetic analogue of vasopressin and acts as an antidiuretic hormone. Desmopressin nasal spray is used as antidiuretic replacement therapy in the management of central diabetes insipidus, helping regulate excessive urine production associated with inadequate antidiuretic hormone activity.

With its specialized nasal dosage form, Desolivo can be considered for pharmaceutical portfolios focused on endocrinology and specialized therapeutic segments.

Composition

Desmopressin Nasal Spray – 0.1 mg/mL

Product Specifications

Particular	Details
Brand Name	Desolivo
Generic Name	Desmopressin
Dosage Form	Nasal Spray
Strength	0.1 mg/mL
Metered Doses	50
Therapeutic Segment	Antidiuretic Therapy / Endocrinology
Company	Farlex Pharmaceuticals Pvt. Ltd.

What Is Desolivo Nasal Spray Used For?

Desolivo contains desmopressin and is used as antidiuretic replacement therapy in the management of central diabetes insipidus. Desmopressin acts similarly to the body's natural vasopressin hormone and helps reduce excessive urine production by promoting water reabsorption.

The product should be used strictly according to the prescribing information and direction of the treating healthcare professional.

Key Product Highlights

Desmopressin nasal spray formulation
0.1 mg/mL strength
50 metered-dose presentation
Specialized nasal dosage form
Used in antidiuretic therapy
Relevant to the endocrinology and diabetes-insipidus segment
Suitable for specialized pharmaceutical product portfolios
B2B opportunity for pharma distributors, PCD partners and pharma marketers

B2B Pharma Portfolio Opportunity

Specialized pharmaceutical products can add depth to a company's therapeutic portfolio by addressing focused healthcare segments.

Desolivo Nasal Spray provides a desmopressin-based nasal formulation for businesses looking to develop or expand a portfolio in specialized therapeutic areas such as endocrinology and antidiuretic therapy.

The product can be relevant for PCD pharma franchise partners, pharmaceutical distributors, stockists, super stockists, pharma marketers and institutional pharmaceutical buyers, subject to applicable commercial and regulatory requirements.

Why Consider Desolivo for Your Pharma Portfolio?

Desolivo combines a recognized active ingredient with a specialized nasal dosage form and a convenient metered-dose presentation.

Product advantages for portfolio planning:

Specialized therapeutic category
Desmopressin-based formulation
Nasal spray delivery format
0.1 mg/mL strength
50 metered doses
Suitable for focused endocrinology-related portfolios
Potential addition for pharmaceutical businesses serving appropriate healthcare channels

Packing

50 Metered Doses – Nasal Spray

Strength: 0.1 mg/mL

The commercial pack configuration should be confirmed from the latest approved product specification before placing an order or publishing regulatory/commercial information.

Ideal B2B Buyers

Desolivo Nasal Spray may be relevant for:

PCD Pharma Franchise Partners
Pharma Distributors
Stockists & Super Stockists
Pharma Marketing Companies
Institutional Pharmaceutical Suppliers
Specialty Pharma Portfolio Owners
Pharmaceutical Business Partners
Export / International Pharma Buyers, subject to applicable regulatory requirements

Business Enquiry

Looking to add a Desmopressin Nasal Spray to your pharmaceutical portfolio?

Connect with Farlex Pharmaceuticals Pvt. Ltd. for product availability, commercial information, business partnership opportunities and the applicable product range.

Enquire Now for Product & Business Details.